EN
HI
Jagsonpal Pharmaceuticals Share Price
JAGSNPHARM
209.271.15 (-0.55%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 22 Nov, 2026, Jagsonpal Pharmaceuticals stock price is ₹209.27. During the trading session, the stock has moved between an intraday low of ₹206.11 and an intraday high of ₹212.90. Over the last 52 weeks, Jagsonpal Pharmaceuticals has traded between ₹155.00 and ₹264.50.
The stock has recorded a trading volume of 18,367 shares,. Its Average Traded Price (ATP) is ₹207.80, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 31 @ ₹209.27.
Jagsonpal Pharmaceuticals has an upper circuit limit of ₹252.50 and a lower circuit limit of ₹168.34. The total value traded stands at ₹38.17 L, and the delivery percentage for the day is 49.28%.
The stock is currently traded with a market lot size of 1. Jagsonpal Pharmaceuticals also offers a dividend yield of 0%.
Jagsonpal Pharmaceuticals Share Price Chart
Jagsonpal Pharmaceuticals Share Key Metrics
Volume
18367.00
Market Cap
1380.29 CR
LTQ@LTP
31@209.27
ATP
207.8
Var Margin
19.12 %
Circuit Range
168.34-252.5
Delivery %
49.28 %
Value
38.17 L
ASM/GSM
No
Market Lot
1
Jagsonpal Pharmaceuticals Resistance and Support
Pivot 209.93
Resistance
First Resistance
213.9
Second Resistance
217.37
Third Resistance
221.34
Support
First Support
206.46
Second Support
202.49
Third Support
199.02
Jagsonpal Pharmaceuticals Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
68.81%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
2.13%
Domestic Institutional Investors
1.66%
Retail
27.4%
Others
0%
Total Promoters
MAR '26
67.89%
JUN '26
69.05%
SEP '26
68.81%
Jagsonpal Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-28 | Quarterly Results |
| 2026-07-29 | Quarterly Results |
| 2026-04-27 | Audited Results & Final Dividend |
| 2026-03-12 | Buy Back of Shares |
| 2026-01-21 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-07-26 | Quarterly Results |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-01-22 | Quarterly Results |
| 2024-10-23 | Quarterly Results & Stock Split |
| 2024-08-07 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-09-04 | 2026-09-04 | View More |
| Split Ratio | Split Date | |
|---|---|---|
| 2.5:1 | 2025-01-08 | View More |
| Buyback Period | ||
|---|---|---|
| 19 Nov - 26 Nov 26 12.30 pm | View More |
Jagsonpal Pharmaceuticals News
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jagsonpal Pharmaceuticals reported Q2 FY27 cons. revenue of Rs.96.4 crore, marking a 29% YoY growth, with a net profit of Rs.12.3 crore. The performance was driven by a 9.3% rise in the standalone business and the strategic consolidation of Aequitas Healthcare.
Oct 28 2026 18:41:36
Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting
Jagsonpal Pharmaceuticals reported Q2 FY27 cons. revenue of ₹96.37 crore and net profit of ₹12.29 crore. The company also announced the acquisition of an 85% stake in Aequitas Healthcare for ₹20.80 crore and a pact to acquire the Wellness Portfolio of Group Pharmaceuticals.
Oct 28 2026 18:09:35
Jagsonpal Pharmaceuticals Management
| Name | Position |
|---|---|
| Pratham Rawal | Company Secretary & Compliance Officer |
| Harsha Raghavan | Chairperson |
Jagsonpal Pharmaceuticals Similar Stocks
Suraksha Diagnostic Ltd.
312.00
-17.90 (5.43%)
NGL Fine-Chem Ltd.
2752.60
-24.40 (0.88%)
Bharat Parenterals Ltd.
2300.00
-101.00 (4.21%)
Krsnaa Diagnostics Ltd.
519.80
4.15 (0.80%)
Amrutanjan Health Care Ltd.
514.50
-2.55 (0.49%)
Anlon Healthcare Ltd.
25.17
0.20 (0.80%)
Fermenta Biotech Ltd.
442.50
-19.80 (4.28%)
KMC Speciality Hospitals (India) Ltd.
203.78
2.14 (1.06%)
Shalby Ltd.
121.26
-0.63 (0.52%)
Kopran Ltd.
264.40
-2.65 (0.99%)
Jagsonpal Pharmaceuticals FAQs
The Buying Price of Jagsonpal Pharmaceuticals share is 209.27 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jagsonpal Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jagsonpal Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jagsonpal Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jagsonpal Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jagsonpal Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.61 & 2.57 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jagsonpal Pharmaceuticals is 1380.29 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jagsonpal Pharmaceuticals share price is 264.50 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jagsonpal Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in JAGSNPHARM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in JAGSNPHARM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade